Thyroid cancer is a common endocrine malignancy and its morbidity raised rapidly in recent years.The association between TERT promoter mutations(C228 T,C250T) and clinical outcomes have been investigated since they were confirmed in thyroid cancer(including differentiated thyroid cancer and anaplastic thyroid cancer) in 2013.Most studies suggest the mutations are associated with thyroid cancer,the clinical outcomes and poor prognosis.The two mutations are considered to be oncogenic mutations.In order to pro...